SPHERA FUNDS MANAGEMENT LTD.
Adviser information for SPHERA FUNDS MANAGEMENT LTD. last updated from Form ADV on March 6th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Other (specify) |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Israel |
Employees
| Total Number of Employees | 0 |
|---|---|
| Investment Advisory/Research | 0 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | No |
|---|
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 0 | $0 |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 0 |
Services
| Advisory Services | – |
|---|---|
| Compensation | – |
Principal Office
4 YITZHAK SADE ST.TEL AVIV
Israel
SUNDAY-THURSDAY, 0900-1800
Tel: 972-3-6845535, Fax: +972-3-6845621
Websites
Chief Compliance Officer
ADI HANETZ
GENERAL COUNSEL
4 YITZHAK SADE ST.
TEL AVIV
Israel
Tel:
+972-3-6845535
Fax:
+972-3-6845621
A*********@*************M
(Full email address available in API data)
Industry Affiliates
| SPHERA BIOTECH | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SPHERA CAPITAL GP | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SPHERA CAPITAL LTD | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| SPHERA GLOBAL EQUITIES | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SPHERA GLOBAL EQUITIES | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| SPHERA GLOBAL HEALTHCARE | Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SPHERA GP | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SPHERA MANAGEMENT TECHNOLOGY FUNDS LTD | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
| SPHERA PORTFOLIO MANAGEMENT LTD | Other investment adviser, including financial planners |
| SPHERA TECH GP LP | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| SPHERA MASTER FUND LP | Hedge Fund | $640.4M | $0.5M | 281 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| HANETZ, ADI | Individual | – | GENERAL COUNSEL, CHIEF COMPLIANCE OFFICER | 07/2011 | < 5% |
| ELPELEG, NEOMI | Individual | – | CHIEF FINANCIAL OFFICER | 07/2010 | < 5% |
| GELBARD, EHUD, ZVI | Individual | – | SHAREHOLDER | 09/2009 | 5-10% |
| KERENDOR LTD. | Foreign Entity | – | SHAREHOLDER | 01/2004 | 10-25% |
| YAAD CONSULTING AND MANAGEMENT SERVICES (1995) LTD | Foreign Entity | – | SHAREHOLDER | 01/2004 | 5-10% |
| AVDINCO LTD | Foreign Entity | – | SHAREHOLDER | 03/2011 | 10-25% |
| MOR MITER (2004) LTD | Foreign Entity | – | SHAREHOLDER | 01/2004 | 10-25% |
| R.Y. SENATOR INVESTMENTS LTD | Foreign Entity | – | SHAREHOLDER | 01/2004 | 10-25% |
| KERENDOR HOLDINGS (2004) LTD | Foreign Entity | KERENDOR LTD. | OWNER | 01/2004 | > 75% |
| MOR MITER HOLDINGS LTD | Foreign Entity | MOR MITER (2004) LTD | OWNER | 01/2004 | > 75% |
| LENROK HOLDINGS LTD | Foreign Entity | R.Y. SENATOR INVESTMENTS LTD | OWNER | 01/2004 | > 75% |
| SAGIE, MALI | Individual | – | DIRECTOR | 03/2011 | < 5% |
| SENATOR, RON | Individual | – | DIRECTOR | 01/2004 | < 5% |
| BREEN, KEREN | Individual | KERENDOR HOLDINGS (2004) LTD | OWNER | 01/2004 | > 75% |
| MOR, MIRIAM | Individual | MOR MITER HOLDINGS LTD | OWNER | 01/2004 | > 75% |
| SENATOR, YAEL | Individual | LENROK HOLDINGS LTD | OWNER | 01/2004 | > 75% |
| SHALEV, EDDY | Individual | – | SHAREHOLDER / DIRECTOR | 09/2009 | 5-10% |
| SHREM, ITSCHAK | Individual | YAAD CONSULTING AND MANAGEMENT SERVICES (1995) LTD | OWNER | 01/1995 | > 75% |
| LIKVORNIK, RONNIT COHEN | Individual | AVDINCO LTD | OWNER | 02/2018 | 25-50% |
| SALOMI, DANIELLA COHEN | Individual | AVDINCO LTD | OWNER | 02/2018 | 25-50% |
| LEVI, AMIR | Individual | – | CHIEF EXECUTIVE OFFICER | 02/2022 | < 5% |
| LEVI, OSHRAT | Individual | – | CHIEF OPERATING OFFICER | 07/2022 | < 5% |
| BREEN, DORON | Individual | – | DIRECTOR | 08/2023 | < 5% |
| MOR, EREZ | Individual | – | DIRECTOR | 08/2023 | < 5% |
No. Employees, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| 4D MOLECULAR THERAPEUTICS IN | COM | 5M | 243K | 1,2 |
| 89BIO INC | COM | 4M | 527K | 1,2 |
| ABBVIE INC | COM | 7M | 38K | 1,2 |
| ACADIA PHARMACEUTICALS INC | COM | 5M | 328K | 1,2 |
| ADC THERAPEUTICS SA | SHS | 2M | 686K | 1,2 |
| AKERO THERAPEUTICS INC | COM | 3M | 142K | 1,2 |
| ALECTOR INC | COM | 3M | 610K | 1,2 |
| ALUMIS INC | COM | 2M | 125K | 1,2 |
| AMAZON COM INC | COM | 20M | 101K | – |
| AMYLYX PHARMACEUTICALS INC | COM | 68K | 36K | 1,2 |
| ANALOG DEVICES INC | COM | 3M | 13K | – |
| APPLE INC | COM | 13M | 62K | – |
| APPLIED MATLS INC | COM | 6M | 25K | – |
| APPLIED THERAPEUTICS INC | COM | 3M | 674K | 1,2 |
| APREA THERAPEUTICS INC | COM NEW | 1M | 270K | 1,2 |
| ARBE ROBOTICS LTD | ORDINARY SHARES | 82K | 43K | – |
| ARGENX SE | SPONSORED ADR | 669K | 2K | 1,2 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 1M | 48K | 1,2 |
| ASML HOLDING N V | N Y REGISTRY SHS | 10M | 10K | – |
| ASTRAZENECA PLC | SPONSORED ADR | 15M | 190K | 1,2 |
| ASTRIA THERAPEUTICS INC | COM | 1M | 163K | 1,2 |
| BIOGEN INC | COM | 11M | 47K | 1,2 |
| BRIDGEBIO PHARMA INC | COM | 23M | 910K | 1,2 |
| BRIDGEBIO PHARMA INC | COM | 5M | 205K | 1,2 |
| BROADCOM INC | COM | 3M | 19K | – |
| CAMTEK LTD | ORD | 243K | 2K | – |
| CARGO THERAPEUTICS INC | COM | 3M | 156K | 1,2 |
| CARTESIAN THERAPEUTICS INC | COM NEW | 677K | 25K | 1,2 |
| CATALYST PHARMACEUTICALS INC | COM | 4M | 288K | 1,2 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 11M | 309K | 1,2 |
| COMPUGEN LTD | ORD | 1M | 739K | 1,2 |
| CYBIN INC | COM | 7M | 26M | 1,2 |
| CYTOKINETICS INC | COM NEW | 21M | 385K | 1,2 |
| DAY ONE BIOPHARMACEUTICALS I | COM | 5M | 348K | 1,2 |
| DISC MEDICINE INC | COM | 3M | 58K | 1,2 |
| ELEDON PHARMACEUTICALS INC | COM | 3M | 1M | 1,2 |
| ELEVATION ONCOLOGY INC | COM | 891K | 330K | 1,2 |
| ELI LILLY & CO | COM | 12M | 13K | 1,2 |
| ELIEM THERAPEUTICS INC | COM | 2M | 215K | 1,2 |
| ENLIGHT RENEWABLE ENERGY LTD | SHS | 3M | 169K | – |
| ENPHASE ENERGY INC | COM | 6M | 57K | – |
| FULCRUM THERAPEUTICS INC | COM | 366K | 59K | 1,2 |
| GLOBAL E ONLINE LTD | SHS | 2M | 67K | – |
| GOSSAMER BIO INC | COM | 200K | 222K | 1,2 |
| GSK PLC | SPONSORED ADR | 4M | 100K | 1,2 |
| ICL GROUP LTD | SHS | 459K | 107K | – |
| IMMATICS N.V | *W EXP 07/01/202 | 277K | 100K | 1,2 |
| IMMATICS N.V | SHS | 8M | 731K | 1,2 |
| INOZYME PHARMA INC | COM | 7M | 1M | 1,2 |
| INSMED INC | COM PAR $.01 | 1M | 17K | 1,2 |
| INTELLIA THERAPEUTICS INC | COM | 3M | 139K | 1,2 |
| INVESCO QQQ TR | UNIT SER 1 | 11M | 23K | – |
| IONIS PHARMACEUTICALS INC | COM | 7M | 140K | 1,2 |
| JASPER THERAPEUTICS INC | COM NEW | 10M | 454K | 1,2 |
| JFROG LTD | ORD SHS | 4M | 118K | – |
| JOHNSON & JOHNSON | COM | 10M | 70K | 1,2 |
| KEZAR LIFE SCIENCES INC | COM | 1M | 2M | 1,2 |
| KLA CORP | COM NEW | 3M | 3K | – |
| KURA ONCOLOGY INC | COM | 13M | 611K | 1,2 |
| KYVERNA THERAPEUTICS INC | COM | 2M | 236K | 1,2 |
| L3HARRIS TECHNOLOGIES INC | COM | 2M | 10K | – |
| LAM RESEARCH CORP | COM | 4M | 4K | – |
| LARIMAR THERAPEUTICS INC | COM | 2M | 312K | 1,2 |
| LAVA THERAPEUTICS NV | SHS | 662K | 368K | 1,2 |
| MARVELL TECHNOLOGY INC | COM | 1M | 20K | – |
| MERCK & CO INC | COM | 7M | 60K | 1,2 |
| MERUS N V | COM | 9M | 148K | 1,2 |
| META PLATFORMS INC | CL A | 17M | 33K | – |
| MICRON TECHNOLOGY INC | COM | 5M | 37K | – |
| MICROSOFT CORP | COM | 15M | 33K | – |
| MINERALYS THERAPEUTICS INC | COM | 5M | 443K | 1,2 |
| MONTE ROSA THERAPEUTICS INC | COM | 1M | 375K | 1,2 |
| NICE LTD | SPONSORED ADR | 14M | 81K | – |
| NICE LTD | SPONSORED ADR | 6M | 32K | – |
| NOVARTIS AG | SPONSORED ADR | 5M | 50K | 1,2 |
| NOVO-NORDISK A S | ADR | 11M | 78K | 1,2 |
| NUTRIEN LTD | COM | 2M | 41K | – |
| NVIDIA CORPORATION | COM | 2M | 20K | – |
| OUTLOOK THERAPEUTICS INC | COM | 4M | 571K | 1,2 |
| PALO ALTO NETWORKS INC | COM | 6M | 18K | – |
| PERION NETWORK LTD | SHS NEW | 2M | 235K | – |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 8M | 787K | 1,2 |
| PFIZER INC | COM | 3M | 90K | 1,2 |
| PHARVARIS N V | COM | 8M | 403K | 1,2 |
| PLIANT THERAPEUTICS INC | COM | 3M | 259K | 1,2 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 12M | 283K | 1,2 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 3M | 75K | 1,2 |
| PRIME MEDICINE INC | COM | 655K | 127K | 1,2 |
| PROMIS NEUROSCIENCES INC | COM NEW | 3M | 2M | 1,2 |
| PTC THERAPEUTICS INC | COM | 3M | 94K | 1,2 |
| QUALCOMM INC | COM | 4M | 19K | – |
| REZOLUTE INC | COM NEW | 7M | 2M | 1,2 |
| ROCKET PHARMACEUTICALS INC | COM | 4M | 207K | 1,2 |
| SALESFORCE INC | COM | 9M | 34K | – |
| SANOFI | SPONSORED ADR | 22M | 450K | 1,2 |
| SAREPTA THERAPEUTICS INC | COM | 13M | 84K | 1,2 |
| SAREPTA THERAPEUTICS INC | COM | 2M | 15K | 1,2 |
| SAVARA INC | COM | 4M | 963K | 1,2 |
| SENTINELONE INC | CL A | 6M | 284K | – |
| SHL TELEMEDICINE LTD | SPONSORED ADS | 3M | 632K | – |
| SKYE BIOSCIENCE INC | COM NEW | 10M | 1M | 1,2 |
| SPRINGWORKS THERAPEUTICS INC | COM | 3M | 70K | 1,2 |
| SYNDAX PHARMACEUTICALS INC | COM | 17M | 822K | 1,2 |
| TABOOLA.COM LTD | ORD SHS | 2M | 667K | – |
| TAIWAN SEMICONDUCTOR MFG LTD | SPONSORED ADS | 982K | 6K | – |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 6M | 375K | 1,2 |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 7M | 414K | – |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 53M | 3M | – |
| TOWER SEMICONDUCTOR LTD | SHS NEW | 6M | 150K | – |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 12M | 294K | 1,2 |
| UPWORK INC | COM | 1M | 117K | – |
| VANECK ETF TRUST | SEMICONDUCTR ETF | 39M | 150K | – |
| VARONIS SYS INC | COM | 768K | 16K | – |
| VENTYX BIOSCIENCES INC | COM | 2M | 1M | 1,2 |
| VIGIL NEUROSCIENCE INC | COM | 7M | 2M | 1,2 |
| VIR BIOTECHNOLOGY INC | COM | 1M | 162K | 1,2 |
| VISTAGEN THERAPEUTICS INC | COM | 3M | 809K | 1,2 |
| WEREWOLF THERAPEUTICS INC | COM | 2M | 627K | 1,2 |
| WIX COM LTD | SHS | 4M | 25K | – |